Drug Type Small molecule drug |
Synonyms RENESE-R |
Target |
Action inhibitors |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), VMAT2 inhibitors(Synaptic vesicular amine transporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (15 Oct 1963), |
Regulation- |
Molecular FormulaC11H13ClF3N3O4S3 |
InChIKeyCYLWJCABXYDINA-UHFFFAOYSA-N |
CAS Registry346-18-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hypertension | United States | 15 Oct 1963 |





